Kobayashi Pharmaceutical Co Ltd
TSE:4967
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Price:
5 564 JPY
-3%
Market Closed
Updated:
May 20, 2024
Kobayashi Pharmaceutical Co Ltd
Operating Expenses
|
Kobayashi Pharmaceutical Co Ltd
Operating Expenses Peer Comparison
Comparables:
4911
4527
4927
4452
F
4921
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Operating Expenses
-¥72.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
|
|
Shiseido Co Ltd
TSE:4911
|
Operating Expenses
-¥881.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Operating Expenses
-¥117.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-5%
|
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Operating Expenses
-¥126B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
|
Kao Corp
TSE:4452
|
Operating Expenses
-¥481.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
F
|
Fancl Corp
TSE:4921
|
Operating Expenses
-¥61.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-2%
|
See Also
What is Kobayashi Pharmaceutical Co Ltd's Operating Expenses?
Operating Expenses
-72.3B
JPY
-72.3B
JPY
Based on the financial report for Mar 31, 2024, Kobayashi Pharmaceutical Co Ltd's Operating Expenses amounts to -72.3B JPY.
What is Kobayashi Pharmaceutical Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-3%
-3%
Over the last year, the Operating Expenses growth was -9%. The average annual Operating Expenses growth rates for Kobayashi Pharmaceutical Co Ltd have been -7% over the past three years , 1% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet
